DE vs REGN · P/E 25, rev $45.68B vs P/E 14, rev $14.34B
Deere & Company (DE) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Deere & Company (DE) is a farm & heavy construction machinery company listed on US. It is led by John May.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported DE revenue for 2025-11-02 was $45.68B. Net income was $5.03B. Revenue was down 11.7% from 2024-10-27 to 2025-11-02. DE currently screens at market cap $137.72B and trailing P/E 24.6.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
DE currently screens at market cap $137.72B and trailing P/E 24.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the DE and REGN stock pages for the full models.
Not investment advice.